1. AB0251 Early Onset of Benefit by Patient-Reported Outcomes (PROs) with Sarilumab Treatment in RA. (15th July 2016) Authors: Strand, V.; Chen, C.; Mahajan, P.; Kosinski, M.; Mangan, E.K.; van Hoogstraten, H.; Graham, N.; Lin, Y.; Keystone, E.; Braun, J. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 984 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. AB0252 Benefit of Sarilumab with csDMARDs on Patient Productivity in Work, Household Work and Family, Social, Leisure Activities in TNF-IR RA Patients. (15th July 2016) Authors: Strand, V.; Mahajan, P.; Chen, C.; van Hoogstraten, H.; Mangan, E.K.; Hagino, O.; Graham, N.; Pinheiro, G.da R.C.; Kivitz, A. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 985 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. FRI0228 Sarilumab Dose Reduction To Manage Laboratory Abnormalities in An Open-Label Extension Study in RA Patients. (15th July 2016) Authors: Genovese, M.C.; Fay, J.; Parrino, J.; Garg, A.; van Hoogstraten, H.; Boddy, A.; Martincova, R.; Graham, N.; Simon, J.; Burmester, G.R. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 515 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. OP0028 Effects of Sarilumab plus MTX on Clinical, Radiographic, and Functional Endpoints in Patients with Moderate-To-Severe Rheumatoid Arthritis: Results of A Phase 3, Randomized, Double-Blind, Placebo-Controlled, International Study. (10th June 2014) Authors: Genovese, M.; Fleischmann, R.M.; Kivitz, A.J.; Rell-Bakalarska, M.; Martincova, R.; Fiore, S.; Rohane, P.; van Hoogstraten, H.; Fan, C.; van Adelsberg, J.; Weinstein, S.; Graham, N.; Stahl, N.; Yancopoulos, G.; Huizinga, T.W.; van der Heijde, D. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 70 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. SAT0058 Consistency of Radiographic Responses with Sarilumab plus Methotrexate across Subpopulations of Patients with Rheumatoid Arthritis in A Phase 3 Study. (15th July 2016) Authors: van der Heijde, D.; Fan, C.; van Hoogstraten, H.; Mangan, E.K.; van Adelsberg, J.; Miranda, P.C.; Genovese, M.C. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 685 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. SAT0149 Radiographic Outcomes in Patients Achieving Clinical Remission or Low Disease Activity in A Phase 3 Study of Sarilumab plus Methotrexate in Patients with Active, Moderate-To-Severe Rheumatoid Arthritis. (15th July 2016) Authors: van der Heijde, D.; Simon, J.; van Hoogstraten, H.; Mangan, E.K.; Fay, J.; van Adelsberg, J.; Fan, C.; Genovese, M.C. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 719 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. SAT0160 Clinical and Radiographic Outcomes after 2 Years of Sarilumab in Patients with Rheumatoid Arthritis. (15th July 2016) Authors: van der Heijde, D.; van Adelsberg, J.; Fay, J.; van Hoogstraten, H.; Mangan, E.K.; Graham, N.; Fan, C.; Spindler, A.; Genovese, M.C. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 724 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. SAT0168 Clinical Remission Outcomes with Sarilumab plus Csdmards in Active, Moderate-To-Severe RA Patients with Inadequate Response To Tumor Necrosis Factor Inhibitors. (15th July 2016) Authors: Burmester, G.; Hrycaj, P.; Pacheco-Tena, C.; van Hoogstraten, H.; Mangan, E.K.; Lin, Y.; Bauer, D.; Fay, J.; Parrino, J.; Kivitz, A. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 727 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. SAT0174 Efficacy of Sarilumab plus csDMARDs in Rheumatoid Arthritis Patients Who Had An Inadequate Response To One or More than One Prior TNF Inhibitor. (15th July 2016) Authors: Genovese, M.C.; Pinheiro, G.da R.C.; Mangan, E.K.; Lin, Y.; van Adelsberg, J.; van Hoogstraten, H.; Thompson, D.; Fleischmann, R. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 730 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. SAT0178 Clinical Responses of Sarilumab Based on Rheumatoid Factor and Anti–Cyclic Citrullinated Peptide Antibody Status in Patients with Rheumatoid Arthritis. (15th July 2016) Authors: Emery, P.; van Hoogstraten, H.; Mangan, E.K.; van Adelsberg, J.; Fan, C.; Kivitz, A.; Pinheiro, G.da R.C.; Huizinga, T. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 732 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗